key: cord-0806349-z5d0qh87 authors: Su, Xiaowei W.; Palka, Sydney V.; Rao, Rahul R.; Chen, Fred S.; Brackney, Christopher R.; Cambi, Franca title: SARS‐CoV‐2–associated Guillain‐Barré syndrome with dysautonomia date: 2020-06-01 journal: Muscle Nerve DOI: 10.1002/mus.26988 sha: ae7c5faf80045a7fc301433d3407a7c9a9b452aa doc_id: 806349 cord_uid: z5d0qh87 nan Wuhan, China, showed that those with central nervous system symptoms had lower lymphocyte and platelet counts and higher BUN levels compared with those with peripheral nervous system or no neurological symptoms. 9 Although these laboratory values in the patient we described are similar to those seen in the Wuhan cohort with peripheral nervous system or no neurologic complications, the underlying pathophysiology predisposing certain COVID-19 patients to Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Guillain-Barré syndrome associated with SARS-CoV-2 Guillain-Barré syndrome related to COVID-19 infection Guillain Barré syndrome associated with COVID-19 infection: a case report Guillain-Barré syndrome associated with SARS-CoV-2 infection Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. (to be published) Guillain-Barré syndrome as a Complication of SARS-CoV-2 Infection Guillain-Barré syndrome associated with SARS-CoV-2 infection Neurologic manifestations of hospitalized patients with coronavirus disease